Eagle Pharmaceuticals, Inc. announced that Steven Ratoff, a member of the Board and Chair of the Audit Committee of the Board (the ?Audit Committee?), was appointed Principal Financial Officer and Principal Accounting Officer of the Company, effective immediately. In connection with Mr. Ratoff?s appointment as Interim Chief Financial Officer, Mr. Ratoff stepped down from each of the Audit Committee and Compensation Committee of the Board (the ?Compensation Committee?). Following Mr. Ratoff?s stepping down from these committees, the members of the Audit Committee of the Board are Robert Glenning (Chair), Jennifer Simpson and Richard Edlin, the members of the Compensation Committee are Dr. Simpson (Chair), Mr. Edlin and Luciana Borio, and the members of the Nominating and Corporate Governance Committee are Mr. Edlin (Chair), Mr. Glenning, Dr. Simpson and Dr. Borio.

In addition, the Board appointed Dr. Simpson to serve as the Lead Independent Director of the Board. Mr. Ratoff has served as a member of the Board since March 2007. Mr. Ratoff has served as the Chief Executive Officer of CM Systems LLC, since July 2018.

Mr. Ratoff?s prior experience includes serving as a Venture Partner for ProQuest Investments from 2005 to 2013, as Chief Executive Officer of Novadel Pharma, Inc., from 2007 to 2012, and as Chief Executive Officer of CIMA Labs, Inc. In addition, Mr. Ratoff served as Chief Financial Officer of the Brown-Forman Company from 1995 to 2001. Mr. Ratoff holds a B.S. in business administration from Boston University and an M.B.A. with Distinction from the University of Michigan.